Menu
Back to Journals » Drug Design, Development and Therapy » Volume 2
Original Research
A phase I clinical study of VB4-845: Weekly intratumoral administration of an anti-EpCAM recombinant fusion protein in patients with squamous cell carcinoma of the head and neck
| Total article views | HTML views | PDF downloads | Totals | ||
|---|---|---|---|---|---|
| 6,570 | Dovepress* | 6,570+ | 2,422 | 8,992 | |
| Totals | 6,570 | 2,422 | 8,992 | ||
|
*Since 25 June 2008 +Since July 2016 |
|||||
| Total mentioned | Delicious | Others | |||
|---|---|---|---|---|---|
| 5 | 0 | 0 | 0 | 0 | 5 |
View citations on Google Scholar